The first experiences with cherry breeding at the VSUO in Holouvosy in the Czech Republic date back to the late 1960s. The main variety selected from this programme is Kordia, which in recent years has become one of the world's leading varieties in the medium-late ripening period, mainly due to its high fruit quality standards.
The primary objectives of the WSUO programme are cherry quality (size, texture and colour), resistance to cracking and rot, shelf life and plant productivity. MAS technologies are used in the breeding programme for the early selection of genotypes on several traits: self-fertility, spring frost resistance, drought and climate change tolerance and low chilling requirements.
WSUO, besides Kordia, has commercially propagated 28 cherry varieties. The best known are Early Korvik, Christiana, Felicita, Irena, Justyna, Kasandra, Tamara, Techlovan, Tim and Vanda.
Below is the report of Lubor Zelený, cherry breeding project manager at WSUO in Holouvosy, presented at the workshop on cherry variety innovation at Macfrut 2023.
30 May 2024
Jacob Marsal, research director of Viveros Ebros, explains in this interview how to face the future of variety development, explaining the main demands of customers and giving an overview of the stone fruit season in the Ribera d'Ebre region.
11 Apr 2024
The total export volume reached 2,211,344 crates, an increase of 45.7%. In November, the largest floating photovoltaic plant in South America was officially opened, another milestone in Verfrut's sustainability efforts.
06 Mar 2026
In Chile, the world leader in cherry exports, an INIA study analyzes the evolution of Pseudomonas syringae pv. syringae in commercial orchards. The research highlights local adaptation and copper resistance as key factors for integrated management and sustainable production.
06 Mar 2026
Tart cherries, rich in melatonin, tryptophan and polyphenols, may improve sleep and reduce inflammation and oxidative stress. A review of seven clinical studies analyzed effects on sleep duration, efficiency and biomarkers, with promising but not consistent results.
